News

Avadel Pharmaceuticals to Share Innovations at Healthcare Conference

Avadel Pharmaceuticals to Share Innovations at Healthcare Conference

Avadel Pharmaceuticals Engages at Needham Healthcare Conference

Dublin – Avadel Pharmaceuticals plc (Nasdaq: AVDL), a pioneering biopharmaceutical company dedicated to innovative drug development, is set to make a significant appearance at the 24th Annual Needham Healthcare Conference. Management from Avadel will engage in a thoughtful fireside chat scheduled for April 8 at 1:30 p.m. ET, where they will discuss the company’s strategic direction and pipeline of transformative medicines.

Webcast and Further Engagement

Participants interested in the discussion can access a live webcast of the flameside chat. An archived version will be available on their Investor Relations website for 90 days following the event, allowing for broader accessibility to those unable to attend live.

About Avadel Pharmaceuticals

Avadel Pharmaceuticals is committed to enhancing the lives of patients through innovative treatments. Known for its flagship product, LUMRYZ™, Avadel has made a groundbreaking impact by being the first and only once-at-bedtime oxybate approved by the U.S. Food & Drug Administration (FDA) for treating cataplexy or excessive daytime sleepiness in individuals with narcolepsy aged 7 and older. This advancement illustrates Avadel’s commitment to addressing critical needs in the healthcare sector.

Transformative Solutions in Medicine

The company aims to reshape the treatment landscape by leveraging its expertise in drug formulation and production. Their approach involves not only developing advanced therapeutic options but also focusing on user experience and accessibility, ensuring that patients receive the best possible care. By advocating for innovative solutions, Avadel strives to alleviate challenges faced by patients across various conditions.

Investor and Media Contacts

Avadel Pharmaceuticals values open communication with its stakeholders. For inquiries regarding investments or media coverage, here are the contact details:

Investor Contact

Austin Murtagh
Precision AQ
Email: Austin.Murtagh@precisionAQ.com
Phone: (212) 698-8696

Media Contact

Lesley Stanley
Real Chemistry
Email: lestanley@realchemistry.com
Phone: (609) 273-3162

Frequently Asked Questions

What is the purpose of the fireside chat at the healthcare conference?

The fireside chat aims to provide insights into Avadel's strategic direction and innovations in drug development.

How can I access the presentation from the conference?

You can access the live webcast of the presentation on Avadel's Investor Relations page, with an archived version available for 90 days afterward.

What is LUMRYZ™?

LUMRYZ™ is Avadel's approved product designed for once-at-bedtime oxybate treatment, specifically for patients with narcolepsy.

Who can I contact for investor relations?

Austin Murtagh from Precision AQ is the contact for any investor-related inquiries.

How does Avadel Pharmaceuticals innovate in the biopharmaceutical field?

Avadel focuses on developing innovative treatment options that address the significant challenges faced by patients using current medication therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Selling Montana Cabins: Tips from Shawna Norry

Updated Category News Views 2

Understanding the Challenges of Selling Montana Cabins When folks think about selling real estate, the logistics of marketing quaint Montana cabins or lifestyle properties can be different than your typical city apartment. In the wide-open spaces of places like Libby, Montana, seller needs aren't just about showing a property—it's about telling a story. Shawna Norry, an...

Continue Reading
Call to Action: Make Disease Cure the Top Election Issue

Updated Category News Views 4

A Call for Congressional Accountability The American Center for Cures is banging the drum for change, and they're banging it loud. Founded by Lou Weisbach, this group has come out swinging, urging Americans to slap disease onto the ballot in the midterms. Why? Because dealing with Alzheimer's, diabetes, heart disease, and cancer every year rips a whopping $1.1 trillion...

Continue Reading
Hyliion Faces Legal Drama Over Securities Violations

Updated Category News Views 0

A Stock Tango Entangled in Legal Webs Ah, Hyliion Holdings Corp. (NYSE American: HYLN) finds itself in the legal crosshairs this time around. On October 20, 2026, DJS Law Group sounded the alarm, reminding investors that there’s a class action lawsuit hanging over Hyliion's head like a gray cloud over a picnic. Allegations of securities law violations are the game of...

Continue Reading
iLAB Network Fuels Next-Gen Tech Startups with Innovation

Updated Category News Views 4

Igniting Innovation: 2150's New iLAB Network Here's the skinny on what's cookin' at the 2150 Center for Innovation, Commercialization & Growth. They've bagged another cohort for their iLAB network, and they’re laying the groundwork for the next wave of tech solutions that could shake things up across industries. Fresh Collaborations and Technological Foci Essentially,...

Continue Reading
Prosecco DOC Chef Residency Debriefs on Inaugural Year

Updated Category News Views 1

A Fusion of Flavors: The Residency Recap Alright, listen up. The Prosecco DOC Chef Residency has wrapped its initial bash in Italy, where it played culinary matchmaker with talents from Brazil, South Korea, Canada, and the UK. Picture some top-notch chefs crossing borders and tweaking recipes with that unique Italian spark of Prosecco DOC. It wasn't just some ballroom...

Continue Reading
STEM Grant Boosts Outdoor Learning in Shelbyville

Updated Category News Views 4

Supporting Future Leaders in STEM Some news is like finding a hidden gem in your backyard. This one comes from the hushed fields of Shelbyville, Indiana, where Girls Inc. of Shelbyville is making waves with a $25,000 grant from the American Water Charitable Foundation. It's no surprise that Indiana American Water is celebrating this landmark move, given that they're...

Continue Reading
Dairy Blends Market Eyes USD 15.38B by 2035 Growth

Updated Category News Views 2

The dairy blends market, set to barrel towards USD 15.38 billion by 2035 according to Credence Research, isn't just a numbers game. It's a tug-of-war between different fats, regions, and regulations. For those betting on future market movements, this shouldn't be a passing glance. Rising from USD 9.97 billion in 2025, these figures suggest consistent waves rather than...

Continue Reading
Trive Cashes Out on EarthLink, New Era with Family Offices

Updated Category News Views 1

EarthLink's Changing Hands: What's the Real Deal? I tell you, the tech industry's like a game of hot potato, and right now, EarthLink's the spud getting tossed around. Trive Capital, the private equity force from Dallas, just wrapped up handing EarthLink over to a family office squad. That's WaveDivision Capital, The Pritzker Organization, and Stephens Capital Partners...

Continue Reading
Laredo Oil Eyes Big Gains in Argentina's Oil Play

Updated Category News Views 5

Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...

Continue Reading
Hyliion Partnership Woes: Investors Eye Legal Options

Updated Category News Views 3

Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...

Continue Reading

Top 5 Most Recently Viewed Articles

Protect Your Investment: Join the Domino's Class Action Now

Updated Category News Views 39

Join the Domino's Pizza Class Action As investors, it is crucial to stay informed and vigilant, especially when it comes to your potential investments. Recently, a significant opportunity has arisen for individuals who have purchased securities from Domino's Pizza, Inc. (NYSE: DPZ). Those who have invested between December 7, 2023, and July 17, 2024, should take note of...

Continue Reading
Important Legal Action for Molina Healthcare Investors Ahead

Updated Category News Views 250

Molina Healthcare Investors Encouraged to Take Action Are you an investor in Molina Healthcare, Inc. (NYSE: MOH)? It's crucial to pay attention to recent developments that might affect your investment. A class action lawsuit has emerged which could have significant implications for you. Background of the Lawsuit The Rosen Law Firm, well-known for advocating for investor...

Continue Reading
ACORD Connect 2025: Bridging Collaboration in Insurance

Updated Category News Views 282

ACORD Connect 2025: A New Era of Insurance Collaboration Enjoy a unique virtual conference experience as the ACORD Connect 2025 is set to unveil invaluable insights into the insurance world. This event, hosted in partnership with AXA XL, promises to be an engaging gathering aimed at fostering collaboration and innovation across the industry. Dynamic Agenda Unveiled The...

Continue Reading
Fannie Mae to Discuss Q3 2024 Financial Results in Call

Updated Category News Views 50

Fannie Mae's Upcoming Third Quarter Financial Results Fannie Mae (FNMA) has announced an important date for all stakeholders eager to understand its financial performance. The company is scheduled to release its third-quarter financial results soon. This significant announcement will occur just before the opening of U.S. financial markets, ensuring that investors have the...

Continue Reading
Brilliant Shortlisted for Global Marketing Awards 2026

Updated Category News Views 11

Taking the Spotlight with Influencer Innovation Brilliant's recent achievement didn't come by accident. The marketing and PR agency has found itself on the 2026 Global Influencer Marketing Awards shortlist. Making the cut in two heavyweight categories—Best Retail & eCommerce Influencer Strategy and Most Effective Campaign for ROI—this nod isn't just a pat on the back;...

Continue Reading